This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment—if they stay current with developments in drug therapy.
Get full access to this article
View all access options for this article.
References
1.
KhalilM.E., BasherA.W., BrownE.J., AlhaddadI.A.A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol.2001;37(7): 1757–1764.
2.
JamaliA.H., TangW.H., KhotU.N., FowlerM.B.The role of angiotensin receptor blockers in the management of chronic heart failure. Arch Intern Med.2001; 161(5): 667–672.
HuntS.A., AbrahamW.T., ChinM.H.. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Web Site. http://circ.ahajournals.org/cgi/content/full/112/12/e154. Accessed March 20, 2008.
5.
McMurrayJ.J., OstergrenJ., SwedbergK.. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added Trial. Lancet.2003; 362(9386): 767–771.
6.
PfefferM.A., McMurrayJ.J., VelazquezE.J.. Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction or both. N Engl J Med.2003; 349(20): 1893–1906.
7.
CohnJ.N., TognoniG; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med.2001; 345(23): 1667–1675.
8.
McKelvieR.S., YusufS., PericakD.. the RESOLVD Pilot Study Investigators. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Circulation.1999; 100(10): 1056–1064.
9.
DoultonT.W., HeF.J., MacGregorG.A.Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension.2005; 45(5): 880–806.
10.
KunzR., FriedrichC., WolbersM., MannJ.F.Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med.2008; 148(1): 30–48.
11.
MacKinnonM., ShurrawS., AkbariA., KnollG.A., JaffeyJ., ClarkH.D.Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis.2006; 48(1): 8–20.
12.
JenningsD.L., KalusJ.S., ColemanC.I., ManierskiC., YeeJ.Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis. Diabet Med.2007; 24(5): 486–493.
13.
PhillipsC.O., KashaniA., KoD.K., FrancisG., KrumholzH.M.Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction. Arch Intern Med.2007; 167(18): 1930–1936.
14.
CarsonP.E.Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure. Am Heart J.2000; 140(3): 361–366.
15.
AziziM., MenardJ.Combined blockade of the rennin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation.2004; 109(21): 2492–2499.
16.
FoxA.J., LallooU.G., BelvisiM.G., BernareggiM., ChungK.F., BarnesP.J.Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat med.1996; 2(7): 814–817.
17.
SoodM.M., SoodA.R., RichardsonR.Emergency management and commonly encountered outpatient scenarios in patients with hyperkalemia. Mayo Clin Proc.2007; 82(12): 1553–1561.
